Biofrontera AG Sponsored ADR EBT margin

EBT margin of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBT margin growth rates and interactive chart. The Earnings before tax margin. Calculated as earnings before tax divided by revenue. Measures the profitability of a company after all expenses are paid but before taxes. This is useful to compare various companies in an industry that might have different tax regimes or tax rates.


Highlights and Quick Summary

  • EBT margin for the quarter ending June 30, 2022 was 21.63% (a -105.05% decrease compared to previous quarter)
  • Year-over-year quarterly EBT margin decreased by -120.08%
  • Annual EBT margin for 2021 was 123.96% (a 70.3% increase from previous year)
  • Annual EBT margin for 2021 was 72.79% (a -273.97% decrease from previous year)
  • Annual EBT margin for 2020 was -41.84% (a -0.0% decrease from previous year)
  • Twelve month EBT margin ending June 30, 2022 was 11.62% (a -251.5% decrease compared to previous quarter)
  • Twelve month trailing EBT margin decreased by -120.94% year-over-year
Trailing EBT margin for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
11.62% -7.67% 68.21% -55.49%
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBT margin of Biofrontera AG Sponsored ADR

Most recent EBT marginof BFAGY including historical data for past 10 years.

Interactive Chart of EBT margin of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR EBT margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 21.63% -427.96%
2021 345.0% -107.73% -51.99% -88.99% 123.96%
2020 -11.16% -135.82% 2.75% -84.94% -41.84%
2019 -18.46% -224.05% -38.73% -15.28%
2018 -81.82% -91.29%
2017 -252.53% -134.26% -133.9%
2016 100.0% -172.58%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic